• 1. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acetanilides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Anilides Acetanilides

Professional Introduction to N-(3-Cyanophenyl)acetamide (CAS No. 58202-84-9)

N-(3-cyanophenyl)acetamide, with the chemical identifier CAS No. 58202-84-9, is a significant compound in the field of pharmaceutical chemistry and bioorganic synthesis. This compound has garnered attention due to its versatile applications in medicinal chemistry, particularly in the development of novel therapeutic agents. The structural motif of this molecule, featuring a cyanophenyl group attached to an acetamide moiety, makes it a valuable scaffold for designing molecules with specific biological activities.

The cyanophenyl group, characterized by its electron-withdrawing nature, contributes to the overall electronic properties of the molecule. This feature is particularly useful in modulating the reactivity and binding affinity of the compound towards biological targets. In recent years, there has been a growing interest in leveraging such structural features for the development of drugs that target neurological disorders, inflammatory conditions, and other complex diseases.

N-(3-cyanophenyl)acetamide has been extensively studied in the context of its potential as an intermediate in the synthesis of more complex pharmacophores. The acetamide group provides a polar and hydrogen-bonding capable moiety, which is essential for interactions with biological macromolecules such as proteins and enzymes. This combination of structural features makes it an attractive candidate for further derivatization and optimization.

Recent advancements in computational chemistry have enabled researchers to predict the biological activity of N-(3-cyanophenyl)acetamide with greater precision. Molecular modeling studies have suggested that this compound may exhibit inhibitory effects on certain enzymes implicated in disease pathways. For instance, preliminary computational analyses have indicated potential interactions with cytochrome P450 enzymes, which are crucial in drug metabolism and detoxification processes.

In addition to its theoretical potential, experimental studies have begun to explore the pharmacological properties of N-(3-cyanophenyl)acetamide. Researchers have synthesized various derivatives of this compound and evaluated their efficacy in vitro. These studies have revealed promising results regarding its ability to modulate enzyme activity and cellular responses. Notably, some derivatives have shown significant inhibitory effects on kinases, which are overactive in many cancerous conditions.

The synthesis of N-(3-cyanophenyl)acetamide involves well-established organic chemistry techniques, including nucleophilic substitution reactions and condensation processes. The availability of high-quality starting materials and advanced synthetic methodologies has facilitated efficient production scales suitable for both academic research and industrial applications. The compound's stability under various storage conditions further enhances its utility as a building block in pharmaceutical research.

The growing body of evidence supporting the biological relevance of N-(3-cyanophenyl)acetamide has prompted further investigation into its potential therapeutic applications. Researchers are currently exploring its role in developing treatments for neurodegenerative diseases, where modulation of protein aggregation and oxidative stress are key therapeutic targets. Additionally, its structural features make it a candidate for designing anti-inflammatory agents that target cytokine pathways.

As our understanding of molecular interactions continues to evolve, compounds like N-(3-cyanophenyl)acetamide will play an increasingly important role in drug discovery and development. The integration of traditional organic synthesis with modern biotechnological approaches ensures that such compounds can be rapidly translated from laboratory research to clinical applications. This synergy between chemistry and biology underscores the importance of interdisciplinary collaboration in advancing pharmaceutical sciences.

The future prospects for N-(3-cyanophenyl)acetamide are promising, with ongoing research aimed at expanding its chemical space and exploring new biological functions. Innovations in synthetic chemistry will continue to provide access to novel derivatives with enhanced properties. Furthermore, advances in high-throughput screening technologies will enable faster identification of lead compounds derived from this scaffold.

In conclusion, N-(3-cyanophenyl)acetamide (CAS No. 58202-84-9) represents a compelling example of how structural innovation can drive therapeutic discovery. Its unique combination of chemical features positions it as a valuable asset in the pharmaceutical industry's quest for new treatments. As research progresses, this compound is poised to contribute significantly to our understanding of disease mechanisms and the development of effective therapeutic strategies.

• 321162-59-8(4-Acetamido-2-methylbenzonitrile)
• 35704-19-9(N-(4-Cyanophenyl)acetamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)